Table 4.
Association between TNF‐α polymorphism and CAD
| Genotypes | Univariate analysis OR (95% CI) | P | Multivariate analysis OR (95%CI) | P a | |
|---|---|---|---|---|---|
| CAD patients with<50% obstruction | GG | 1 | ‐ | 1 | ‐ |
| GA | 0.507 (0.33‐0.77) | .002 | 0.96 (0.43‐2.17) | .968 | |
| AA | 0.64 (0.36‐1.13) | .127 | 2.35 (0.64‐8.56) | .193 | |
| CAD patients with ≥50% obstruction | GG | 1 | ‐ | 1 | ‐ |
| GA | 0.73 (0.51‐1.03) | .078 | 1.66 (0.81‐3.40) | .163 | |
| AA | 0.76 (0.47‐1.23) | .276 | 3.56 (1.02‐12.41) | .046 |
OR, Odds ratio.
a
After correction for age, sex, smoking, HDL‐C, TG, LDL‐C, FBG, SBP, DBP, and BMI.